{"prompt": "['Cochlear', 'CIP Number: CBAS5751', 'Principal Investigator Declaration', 'By my signature below, I confirm that I have read, understood and will strictly adhere to the', 'requirements therein. I undertake to ensure that all staff with delegated responsibilities in the conduct', 'of this CIP have also read, understood and will strictly adhere to the requirements therein. This CIP will', 'not be implemented without prior written approval from the Ethics Committee, any applicable National', 'Competent Authorities, and the Sponsor. If amendments to this plan become necessary, written', 'approval by the Ethics Committee and any applicable National Competent Authorities will be obtained', 'before the changes are clinically implemented per the amendment, except under emergency', 'circumstances to protect the rights, safety, and well-being of subjects.', 'Name', 'Title', 'Principal Investigator', 'Site Name', 'Site Address', 'Department of Otorhinolaryngology,', 'Head and Neck Surgery', 'HONG KONG SPECIAL ADMINISTRATIVE', 'Faculty of Medicine', \"REGION OF THE PEOPLE'S REPUBLIC OF\", 'The Chinese University of Hong Kong', 'CHINA', 'Signature', 'Date', 'Template 1278855 Version 1.0', '6 of 75']['Cochlear', 'CIP Number: CBAS5751', 'TABLE OF CONTENTS', 'Investigator Agreement', '3', '1', 'Definitions and Abbreviations', '11', '2', 'Clinical Investigation Synopsis', '13', '3', 'Schedule of Events', '17', '4', 'Background Information and Rationale', '19', '4.1 Introduction', '19', '4.1.1', 'The Baha Systems', '19', '4.1.2', 'The Osia system', '19', '4.2', 'Findings of Previous Nonclinical and Clinical Studies', '20', '4.2.1', 'Nonclinical Data', '20', '4.2.2', 'Clinical Data', '20', '4.3', 'Study Rationale', '22', '5', 'Medical Device Information', '23', '5.1', 'Identity and Description of the Investigational Device', '23', '5.1.1', 'The OSI200 Implant', '24', '5.1.2', 'The Osia 2 Sound Processor (Osia 2 SP)', '24', '5.1.3', 'Osia 2 Sound Processor Magnets', '25', '5.1.4', 'BI300 Implant', '25', '5.1.5', 'Surgery', '26', '5.1.6', 'Training', '26', '5.1.7', 'Manufacturer of investigational device(s)', '27', '5.2', 'Identity and Description of the Reference device', '27', '5.3', 'Accessory Device Requirements', '27', '5.3.1', 'Accessories', '27', '5.3.2', 'The Osia Fitting Software', '28', '5.3.3', 'The Baha Fitting Software', '28', '5.3.4', 'Surgical instruments', '28', '6', 'Objectives', '29', '6.1', 'Primary Objective', '29', '6.2', 'Secondary Objective', '30', '6.3', 'Tertiary Objective', '31', '6.4', 'Exploratory Objective', '31', '7', 'Design of the Clinical Investigation Study', '31', '7.1', 'General', '31', '7.1.1', 'Design Rationale', '32', 'Template 1278855 Version 1.0', '7 of 75']['Cochlear', 'CIP Number: CBAS5751', '7.2 Subjects', '33', '7.2.1', 'Inclusion Criteria', '33', '7.2.2', 'Exclusion Criteria', '34', '7.2.3', 'Number of Subjects Required', '34', '7.2.4', 'Vulnerable Populations', '35', '7.2.5', 'Enrolment & Investigation Duration', '35', '7.2.6', 'Criteria for Subject Withdrawal', '35', '7.2.7', 'Randomisation Procedures', '36', '7.2.8', 'Post-Investigational Medical Care', '36', '7.3', 'Performance Evaluations and Procedures', '36', '7.3.1', 'Eligibility Evaluations and Procedures', '36', '7.3.2', 'Post-Enrolment Evaluations and Procedures', '38', '7.4', 'Safety Evaluations and Procedures', '46', '7.4.1', 'Numbness', '47', '7.4.2', 'Concomitant Medication and Therapies', '47', '7.5', 'Equipment Used for Evaluation of Performance and Safety', '48', '7.6', 'Sponsor Role in Conduct of the Clinical investigation', '48', '8', 'Risks and Benefits of the Investigational device and Clinical Investigation', '48', '8.1', 'Anticipated Clinical Benefits', '48', '8.2', 'Anticipated Adverse Device Effects', '49', '8.3', 'Risks Associated with Participation in the Clinical investigation', '50', '8.4', 'Risk Mitigation', '50', '8.5', 'Risk-to-Benefit Rationale', '51', '9', 'Statistical Considerations', '52', '9.1', 'General Considerations', '52', '9.2', 'Outcome measures', '53', '9.2.1', 'Primary Outcome measures', '53', '9.2.2', 'Secondary Outcome measures', '53', '9.2.3', 'Tertiary Outcome measures', '55', '9.2.4', 'Exploratory Outcome measures.', '55', '9.3 Hypotheses', '55', '9.3.1', 'Primary Hypothesis', '55', '9.3.2', 'Secondary Hypothesis', '56', '9.3.3', 'Exploratory Hypothesis', '57', '9.4', 'Sample Size Determination', '58', '9.5', 'Analysis Populations', '58', 'Template 1278855 Version 1.0', '8 of 75']\n\n###\n\n", "completion": "END"}